Vorapaxar (Zontivity) for prevention of thrombotic cardiovascular events

Med Lett Drugs Ther. 2014 Sep 15;56(1451):85-6.
No abstract available

MeSH terms

  • Drug Approval
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Lactones / administration & dosage*
  • Lactones / adverse effects
  • Lactones / pharmacology
  • Myocardial Infarction / drug therapy
  • Peripheral Arterial Disease / drug therapy
  • Pyridines / administration & dosage*
  • Pyridines / adverse effects
  • Pyridines / pharmacology
  • Receptor, PAR-1 / antagonists & inhibitors
  • Thrombosis / prevention & control*
  • United States
  • United States Food and Drug Administration

Substances

  • Lactones
  • Pyridines
  • Receptor, PAR-1
  • vorapaxar